FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 251 through 282 of 282

- SIC # 2830

Ticker Exchange Company Financial Reports SIC #
TERN Nasdaq Terns Pharmaceuticals, Inc. 2830
TFX New York Teleflex Incorporated 2830
TNYA Nasdaq Tenaya Therapeutics, Inc. 2830
TTRX Nasdaq Turn Therapeutics Inc. 2830
TVGN Nasdaq Tevogen Bio Holdings Inc. 2830
TVTX Nasdaq Travere Therapeutics, Inc. 2830
TYHOY Over the counter Toyota Tsusho Corporation 2830
UCBJY Over the counter UCB SA 2830
UG Nasdaq United-Guardian, Inc. 2830
UPC Nasdaq Universe Pharmaceuticals INC 2830
UTHR Nasdaq United Therapeutics Corporation 2830
VALN Nasdaq Valneva SE 2830
VERA Nasdaq Vera Therapeutics, Inc. 2830
VICP Over the counter Vicapsys Life Sciences, Inc. 2830
VKTX Nasdaq Viking Therapeutics, Inc. 2830
VOR Nasdaq Vor Biopharma Inc. 2830
VRCA Nasdaq Verrica Pharmaceuticals Inc. 2830
VTGN Nasdaq Vistagen Therapeutics, Inc. 2830
VTYX Nasdaq Ventyx Biosciences, Inc. 2830
WALD Nasdaq Waldencast plc 2830
WVE Nasdaq Wave Life Sciences Ltd. 2830
XBIT Nasdaq XBiotech Inc. 2830
XCUR Nasdaq Exicure, Inc. 2830
XENE Nasdaq Xenon Pharmaceuticals Inc. 2830
XFOR Nasdaq X4 Pharmaceuticals, Inc. 2830
XNCR Nasdaq Xencor, Inc. 2830
XOMA Nasdaq XOMA Royalty Corporation 2830
XRTX Nasdaq XORTX Therapeutics Inc. 2830
ZLAB Nasdaq Zai Lab Limited 2830
ZTS New York Zoetis Inc. 2830
ZURA Nasdaq Zura Bio Limited 2830
ZYBT Nasdaq Zhengye Biotechnology Holding Limited 2830
Results 250 through 282 of 282